↓ Skip to main content

Commercialization, patenting and genomics: researcher perspectives

Overview of attention for article published in Genome Medicine, February 2009
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

blogs
3 blogs

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
29 Mendeley
citeulike
2 CiteULike
Title
Commercialization, patenting and genomics: researcher perspectives
Published in
Genome Medicine, February 2009
DOI 10.1186/gm22
Pubmed ID
Authors

CJ Murdoch, Timothy Caulfield

Abstract

The impact of commercialization and patenting pressure on genomics research is still a topic of considerable debate in academic, policy and popular literature. We interviewed genomic researchers to see if their perspectives offered fresh insights. Regional Genome Canada centers provided us with relevant researcher contact information, and in-depth structured interviews were conducted. Researcher perspectives were sharply divided, with both support and concern for commercialization regimes surfacing in interviews. Data withholding and publication delays were commonly reported, but the aggressive enforcement of patents was not. There are parallels to the Stem Cell community in Canada in these respects. Genomic researchers, as individuals directly implicated in the field of controversy, have developed varied and often novel insights which should be incorporated into the ongoing debates surrounding commercialization and patenting. Many researchers continue to raise concerns, particularly in relation to data withholding, thus emphasizing the need for a continued exploration of the complex issues associated with commercialization and patenting.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 29 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 3%
Colombia 1 3%
Brazil 1 3%
Unknown 26 90%

Demographic breakdown

Readers by professional status Count As %
Student > Master 8 28%
Student > Ph. D. Student 4 14%
Student > Bachelor 3 10%
Researcher 3 10%
Student > Doctoral Student 2 7%
Other 4 14%
Unknown 5 17%
Readers by discipline Count As %
Agricultural and Biological Sciences 10 34%
Social Sciences 6 21%
Medicine and Dentistry 4 14%
Economics, Econometrics and Finance 2 7%
Business, Management and Accounting 1 3%
Other 1 3%
Unknown 5 17%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 September 2014.
All research outputs
#2,313,089
of 25,371,288 outputs
Outputs from Genome Medicine
#516
of 1,585 outputs
Outputs of similar age
#7,065
of 108,366 outputs
Outputs of similar age from Genome Medicine
#4
of 14 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,585 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 26.8. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 108,366 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.